Is chronic prostatic inflammation a new target in the medical therapy of lower urinary tract symptoms (LUTS) due to benign prostate hyperplasia (BPH)?-Reference-Cited by-同舟云学术

Is chronic prostatic inflammation a new target in the medical therapy of lower urinary tract symptoms (LUTS) due to benign prostate hyperplasia (BPH)?

Published:2013-07-23 Issue:4 Volume:112 Page:421-422
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Ficarra Vincenzo¹

Affiliation:

1. Department of Oncologic, Surgical and Gastrointestinal Sciences; Urologic Unit; University of Padova; Padova; Italy

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bju.12177/fullpdf

Reference6 articles.

1. The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia;Gandaglia;BJU Int,2013

2. The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial;Nickel;Eur Urol,2008

3. Benign prostatic hyperplasia: age-related tissue-remodeling;Untergasser;Exp Geront,2005

4. The effect of intraprostatic chronic inflammation on benign prostatic hyperplasia treatment;Know;Korean J Urol,2010

5. BPH and inflammation: pharmacological effects of Permixon on histological and molecular inflammatory markers. Results of a double blind pilot clinical assay;Vela Navarrete;Eur Urol,2003

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biochemical and Histopathological evaluation of prostatic tissue under effect of Pterostilbene in benign prostatic hyperplasia rat model;Al Mustansiriyah Journal of Pharmaceutical Sciences;2023-05-23

2. A New Approach for Medicamentous Treatment of Patients with Lower Urinary Tract Symptoms Caused by Benign Prostate Hyperplasia and Chronic Prostatitis. Is It Possible to Prevent the Prostate Cancer?;Health of Man;2022-12-22

3. Effects of metabolic syndrome on benign prostatic hyperplasia;Molecular Mechanisms of Nutritional Interventions and Supplements for the Management of Sexual Dysfunction and Benign Prostatic Hyperplasia;2021

4. Diet as a risk factor and intervention for lower urinary tract symptoms secondary to benign prostatic hyperplasia;Molecular Mechanisms of Nutritional Interventions and Supplements for the Management of Sexual Dysfunction and Benign Prostatic Hyperplasia;2021

5. Inflammation is a target of medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia;World Journal of Urology;2020-02-14